Wells Fargo’s Zura Bio ZURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$317K Buy
+53,776
New +$256K ﹤0.01% 4908
2025
Q3
Sell
-385
Closed -$404 7448
2025
Q2
$404 Sell
385
-23,732
-98% -$28.4K ﹤0.01% 6396
2025
Q1
$31.1K Buy
24,117
+1,064
+5% +$1.68K ﹤0.01% 5554
2024
Q4
$57.6K Buy
23,053
+9,379
+69% +$33.4K ﹤0.01% 5431
2024
Q3
$55.5K Buy
13,674
+7,265
+113% +$27.1K ﹤0.01% 5307
2024
Q2
$22.4K Buy
6,409
+307
+5% +$1.25K ﹤0.01% 5549
2024
Q1
$15.7K Buy
6,102
+773
+15% +$2.74K ﹤0.01% 5641
2023
Q4
$24.9K Buy
5,329
+2,398
+82% +$12K ﹤0.01% 5549
2023
Q3
$19.3K Buy
2,931
+21
+0.7% +$140 ﹤0.01% 5614
2023
Q2
$23.9K Buy
+2,910
New +$23.4K ﹤0.01% 5686

Other funds holding ZURA

Wells Fargo's ZURA Position: Q2 2026 in Review

Wells Fargo opened a new position in Zura Bio (ZURA) in Q2 2026: 53,776 shares worth $317K. The stake represents ﹤0.01% of the portfolio and ranks #4908 among its holdings. This is a return to the name: Wells Fargo previously reported a position in ZURA as recently as Q2 2025.

Wells Fargo first reported a position in ZURA in Q2 2023 and has held it in 10 quarters since. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Wells Fargo held 53,776 shares of Zura Bio worth $317K as of Q2 2026.
  • Zura Bio was a new Wells Fargo position in Q2 2026.
  • Zura Bio made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #4908 holding.
  • Wells Fargo first reported a position in Zura Bio in Q2 2023 and has held it in 10 quarters since.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.